336 related articles for article (PubMed ID: 27829275)
1. Biliary tract cancers: epidemiology, molecular pathogenesis and genetic risk associations.
Marcano-Bonilla L; Mohamed EA; Mounajjed T; Roberts LR
Chin Clin Oncol; 2016 Oct; 5(5):61. PubMed ID: 27829275
[TBL] [Abstract][Full Text] [Related]
2. Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah.
Samadder NJ; Smith KR; Wong J; Hanson H; Boucher K; Burt RW; Charlton M; Byrne KR; Gallegos-Orozco JF; Koptiuch C; Curtin K
Dig Dis Sci; 2016 Dec; 61(12):3627-3632. PubMed ID: 27655103
[TBL] [Abstract][Full Text] [Related]
3. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
[TBL] [Abstract][Full Text] [Related]
4. Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?
Ricci AD; Rizzo A
Medicina (Kaunas); 2021 Nov; 57(12):. PubMed ID: 34946246
[TBL] [Abstract][Full Text] [Related]
5. [Biliary tract cancers : Molecular characterization and identification of novel prognostic markers].
Goeppert B
Pathologe; 2017 Nov; 38(Suppl 2):192-197. PubMed ID: 29063951
[TBL] [Abstract][Full Text] [Related]
6. Biliary Tract Cancer: Epidemiology, Radiotherapy, and Molecular Profiling.
Bridgewater JA; Goodman KA; Kalyan A; Mulcahy MF
Am Soc Clin Oncol Educ Book; 2016; 35():e194-203. PubMed ID: 27249723
[TBL] [Abstract][Full Text] [Related]
7. Biliary Tract and Primary Liver Tumors: Who, What, and Why?
Hemming AW
Surg Oncol Clin N Am; 2019 Oct; 28(4):519-538. PubMed ID: 31472904
[TBL] [Abstract][Full Text] [Related]
8. The present roles and future perspectives of Interleukin-6 in biliary tract cancer.
Zhou M; Na R; Lai S; Guo Y; Shi J; Nie J; Zhang S; Wang Y; Zheng T
Cytokine; 2023 Sep; 169():156271. PubMed ID: 37331095
[TBL] [Abstract][Full Text] [Related]
9. Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study.
Marcano-Bonilla L; Schleck CD; Harmsen WS; Sadr-Azodi O; Borad MJ; Patel T; Petersen GM; Therneau TM; Roberts LR; Brusselaers N
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):804-810. PubMed ID: 35086822
[TBL] [Abstract][Full Text] [Related]
10. Targeted Therapies for Perihilar Cholangiocarcinoma.
Gray S; Lamarca A; Edeline J; Klümpen HJ; Hubner RA; McNamara MG; Valle JW
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406560
[TBL] [Abstract][Full Text] [Related]
11. Translating cancer genomics for precision oncology in biliary tract cancers.
Haber PK; Sia D
Discov Med; 2019; 28(155):255-265. PubMed ID: 32053766
[TBL] [Abstract][Full Text] [Related]
12. Characterizing the burden of biliary tract cancers across 28 hospitals in Ontario, Canada.
Choi WJ; Roberts S; Verma A; Razak F; O'Kane GM; Gallinger S; Hirschfield G; Hansen B; Sapisochin G
Cancer; 2024 Jul; 130(13):2294-2303. PubMed ID: 38361443
[TBL] [Abstract][Full Text] [Related]
13. Brain Metastases from Biliary Tract Cancers: A Case Series and Review of the Literature in the Genomic Era.
D'Andrea MR; Gill CM; Umphlett M; Tsankova NM; Fowkes M; Bederson JB; Brastianos PK; Shrivastava RK
Oncologist; 2020 May; 25(5):447-453. PubMed ID: 31694894
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of biliary tract cancers.
Fairweather M; Balachandran VP; D'Angelica MI
Chin Clin Oncol; 2016 Oct; 5(5):63. PubMed ID: 27829277
[TBL] [Abstract][Full Text] [Related]
15. The role of novel biologics in biliary cancers.
Jordan E; Braghiroli MF; Lowery MA
Minerva Gastroenterol Dietol; 2016 Dec; 62(4):325-339. PubMed ID: 27576672
[TBL] [Abstract][Full Text] [Related]
16. Cell of origin in biliary tract cancers and clinical implications.
Moeini A; Haber PK; Sia D
JHEP Rep; 2021 Apr; 3(2):100226. PubMed ID: 33665585
[TBL] [Abstract][Full Text] [Related]
17. Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapy.
Thomas MB
Crit Rev Oncol Hematol; 2007 Jan; 61(1):44-51. PubMed ID: 17164111
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathology of biliary tract cancers.
Fava G; Marzioni M; Benedetti A; Glaser S; DeMorrow S; Francis H; Alpini G
Cancer Lett; 2007 Jun; 250(2):155-67. PubMed ID: 17069969
[TBL] [Abstract][Full Text] [Related]
19. CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China.
Hou L; Xu J; Gao YT; Rashid A; Zheng SL; Sakoda LC; Shen MC; Wang BS; Deng J; Han TQ; Zhang BH; Meyers DA; Fraumeni JF; Hsing AW
Int J Cancer; 2006 Jun; 118(11):2847-53. PubMed ID: 16381022
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of cholangiocarcinoma.
Qurashi M; Vithayathil M; Khan SA
Eur J Surg Oncol; 2023 Sep; ():107064. PubMed ID: 37709624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
